share_log

CareDx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

ケアDxが第43回年次J.P.モルガンヘルスケアカンファレンスに参加します

Businesswire ·  12/18 20:05

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) - The Transplant Company — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers — today announced that the company will participate in the upcoming 43rd Annual J.P. Morgan Healthcare Conference in San Francisco.



CareDx's management is scheduled to present on Tuesday, January 14, 2025, at 4:30 p.m. Pacific Time (7:30 p.m Eastern Time). To listen to the webcast, please visit the Events & Presentations section of CareDx's Investor Relations website at: investors.caredx.com.

About CareDx – The Transplant Company

CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: .


Contacts

CareDx, Inc.
Media Relations
Anna Czene
818-731-2203
aczene@caredx.com
Investor Relations
Caroline Corner
investor@caredx.com

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする